1,2,4-trimethylbenzene decreases expression EXP 6480464 pseudocumene results in decreased expression of OPLAH protein CTD PMID:17337753 1,2-dimethylhydrazine multiple interactions ISO Oplah (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of OPLAH mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO Oplah (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of OPLAH mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO Oplah (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of OPLAH mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO Oplah (Mus musculus) 6480464 Ethinyl Estradiol results in decreased expression of OPLAH mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Oplah (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of OPLAH mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of OPLAH mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of OPLAH mRNA CTD PMID:16054898 and PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Oplah (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of OPLAH mRNA CTD PMID:19770486 and PMID:19933214 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of OPLAH mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,4-methylenedioxymethamphetamine increases expression ISO Oplah (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of OPLAH mRNA CTD PMID:20188158 4,4'-sulfonyldiphenol decreases methylation ISO Oplah (Mus musculus) 6480464 bisphenol S results in decreased methylation of OPLAH exon CTD PMID:33297965 4,4'-sulfonyldiphenol increases expression ISO OPLAH (Homo sapiens) 6480464 bisphenol S results in increased expression of OPLAH protein CTD PMID:34186270 4-hydroxyphenyl retinamide increases expression ISO Oplah (Mus musculus) 6480464 Fenretinide results in increased expression of OPLAH mRNA CTD PMID:28973697 aflatoxin B1 affects expression ISO OPLAH (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of OPLAH protein CTD PMID:20106945 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of OPLAH mRNA CTD PMID:33354967 aflatoxin B1 decreases expression ISO OPLAH (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of OPLAH mRNA CTD PMID:27153756 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of OPLAH mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO OPLAH (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of OPLAH mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO OPLAH (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of OPLAH mRNA CTD PMID:33212167 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of OPLAH mRNA CTD PMID:33854195 belinostat multiple interactions ISO OPLAH (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OPLAH mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression ISO OPLAH (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of OPLAH mRNA CTD PMID:20106945 and PMID:32234424 benzo[a]pyrene increases methylation ISO OPLAH (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of OPLAH promoter CTD PMID:27901495 bis(2-ethylhexyl) phthalate increases expression ISO Oplah (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of OPLAH mRNA CTD PMID:19850644 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of OPLAH mRNA CTD PMID:25181051 bisphenol A affects expression ISO OPLAH (Homo sapiens) 6480464 bisphenol A affects the expression of OPLAH protein CTD PMID:34186270 bisphenol A multiple interactions ISO OPLAH (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of OPLAH gene CTD PMID:31601247 bisphenol A increases expression ISO Oplah (Mus musculus) 6480464 bisphenol A results in increased expression of OPLAH mRNA CTD PMID:33221593 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of OPLAH mRNA CTD PMID:30816183 Bisphenol B increases expression ISO OPLAH (Homo sapiens) 6480464 bisphenol B results in increased expression of OPLAH protein CTD PMID:34186270 bisphenol F increases expression ISO OPLAH (Homo sapiens) 6480464 bisphenol F results in increased expression of OPLAH protein CTD PMID:34186270 buspirone increases expression EXP 6480464 Buspirone results in increased expression of OPLAH mRNA CTD PMID:24136188 cadmium dichloride affects methylation EXP 6480464 Cadmium Chloride affects the methylation of OPLAH promoter CTD PMID:22457795 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of OPLAH mRNA CTD PMID:33854195 cisplatin multiple interactions ISO OPLAH (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of OPLAH mRNA CTD PMID:27392435 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of OPLAH mRNA CTD PMID:24386269 copper atom decreases expression EXP 6480464 Copper results in decreased expression of OPLAH mRNA CTD PMID:22465980 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of OPLAH mRNA CTD PMID:22465980 corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of OPLAH mRNA CTD PMID:15755911 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of OPLAH mRNA CTD PMID:27523638 cyclosporin A decreases expression ISO OPLAH (Homo sapiens) 6480464 Cyclosporine results in decreased expression of OPLAH mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO Oplah (Mus musculus) 6480464 Cyclosporine results in decreased expression of OPLAH mRNA CTD PMID:19770486 diquat increases expression ISO Oplah (Mus musculus) 6480464 Diquat results in increased expression of OPLAH mRNA CTD PMID:36851058 dorsomorphin multiple interactions ISO OPLAH (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of OPLAH mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO Oplah (Mus musculus) 6480464 epoxiconazole results in decreased expression of OPLAH mRNA CTD PMID:35436446 ethanol increases expression ISO Oplah (Mus musculus) 6480464 Ethanol results in increased expression of OPLAH mRNA CTD PMID:30319688 fenthion decreases expression ISO Oplah (Mus musculus) 6480464 Fenthion results in decreased expression of OPLAH mRNA CTD PMID:34813904 finasteride increases expression EXP 6480464 Finasteride results in increased expression of OPLAH mRNA CTD PMID:24136188 folic acid multiple interactions ISO Oplah (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of OPLAH mRNA CTD PMID:22206623 FR900359 increases phosphorylation ISO OPLAH (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of OPLAH protein CTD PMID:37730182 fulvestrant multiple interactions ISO OPLAH (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of OPLAH gene CTD PMID:31601247 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of OPLAH mRNA CTD PMID:24136188 glyphosate decreases expression ISO Oplah (Mus musculus) 6480464 Glyphosate results in decreased expression of OPLAH protein CTD PMID:37208198 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of OPLAH mRNA CTD PMID:33854195 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of OPLAH mRNA CTD PMID:33854195 ivermectin decreases expression ISO OPLAH (Homo sapiens) 6480464 Ivermectin results in decreased expression of OPLAH protein CTD PMID:32959892 ketamine increases expression EXP 6480464 Ketamine results in increased expression of OPLAH mRNA CTD PMID:20080153 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of OPLAH mRNA CTD PMID:35283115 mercury dibromide multiple interactions ISO OPLAH (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OPLAH mRNA CTD PMID:27188386 Mesaconitine decreases expression EXP 6480464 mesaconitine results in decreased expression of OPLAH protein CTD PMID:37182599 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of OPLAH mRNA CTD PMID:16393664 methidathion decreases expression ISO Oplah (Mus musculus) 6480464 methidathion results in decreased expression of OPLAH mRNA CTD PMID:34813904 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of OPLAH gene CTD PMID:35440735 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of OPLAH mRNA CTD PMID:21515302 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of OPLAH mRNA CTD PMID:19638242 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of OPLAH protein CTD PMID:19716841 p-chloromercuribenzoic acid decreases expression ISO OPLAH (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in decreased expression of OPLAH mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO OPLAH (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OPLAH mRNA CTD PMID:27188386 paracetamol decreases expression ISO OPLAH (Homo sapiens) 6480464 Acetaminophen results in decreased expression of OPLAH mRNA CTD PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of OPLAH mRNA CTD PMID:33387578 perfluorooctanoic acid increases expression ISO OPLAH (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of OPLAH mRNA CTD PMID:36326898 phenobarbital multiple interactions ISO Oplah (Mus musculus) 6480464 NR1I3 protein promotes the reaction [Phenobarbital results in decreased expression of OPLAH mRNA] CTD PMID:19850644 phenobarbital decreases expression ISO Oplah (Mus musculus) 6480464 Phenobarbital results in decreased expression of OPLAH mRNA CTD PMID:19850644 phenylmercury acetate decreases expression ISO OPLAH (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of OPLAH mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO OPLAH (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OPLAH mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO Oplah (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of OPLAH mRNA and PPARA protein promotes the reaction [pirinixic acid results in decreased expression of OPLAH mRNA] CTD PMID:19710929 and PMID:19850644 pirinixic acid increases expression ISO Oplah (Mus musculus) 6480464 pirinixic acid results in increased expression of OPLAH mRNA CTD PMID:17426115 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of OPLAH mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile increases expression ISO Oplah (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of OPLAH mRNA CTD PMID:28903501 progesterone increases expression EXP 6480464 Progesterone results in increased expression of OPLAH mRNA CTD PMID:20726854 resveratrol multiple interactions ISO OPLAH (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of OPLAH mRNA CTD PMID:23557933 SB 431542 multiple interactions ISO OPLAH (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of OPLAH protein CTD PMID:29459688 sodium arsenite decreases expression ISO OPLAH (Homo sapiens) 6480464 sodium arsenite results in decreased expression of OPLAH mRNA CTD PMID:37956786 sodium arsenite increases expression ISO OPLAH (Homo sapiens) 6480464 sodium arsenite results in increased expression of OPLAH mRNA CTD PMID:34032870 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of OPLAH mRNA CTD PMID:25993096 sodium fluoride increases expression ISO Oplah (Mus musculus) 6480464 Sodium Fluoride results in increased expression of OPLAH protein CTD PMID:28918527 sulforaphane decreases expression ISO OPLAH (Homo sapiens) 6480464 sulforaphane results in decreased expression of OPLAH mRNA CTD PMID:31838189 sunitinib increases expression ISO OPLAH (Homo sapiens) 6480464 Sunitinib results in increased expression of OPLAH mRNA CTD PMID:31533062 tamoxifen affects expression ISO Oplah (Mus musculus) 6480464 Tamoxifen affects the expression of OPLAH mRNA CTD PMID:17555576 temozolomide increases expression ISO OPLAH (Homo sapiens) 6480464 Temozolomide results in increased expression of OPLAH mRNA CTD PMID:31758290 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of OPLAH mRNA CTD PMID:21515302 tetrachloroethene increases expression ISO Oplah (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of OPLAH mRNA CTD PMID:28973375 tetrachloromethane affects expression ISO Oplah (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of OPLAH mRNA CTD PMID:17484886 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of OPLAH mRNA CTD PMID:33854195 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of OPLAH mRNA CTD PMID:23411599 triptonide increases expression ISO Oplah (Mus musculus) 6480464 triptonide results in increased expression of OPLAH mRNA CTD PMID:33045310 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of OPLAH mRNA CTD PMID:21515302 trovafloxacin decreases expression ISO Oplah (Mus musculus) 6480464 trovafloxacin results in decreased expression of OPLAH mRNA CTD PMID:35537566 urethane decreases expression ISO OPLAH (Homo sapiens) 6480464 Urethane results in decreased expression of OPLAH mRNA CTD PMID:28818685 ursodeoxycholic acid decreases expression EXP 6480464 Ursodeoxycholic Acid results in decreased expression of OPLAH mRNA CTD PMID:15885361 valproic acid decreases expression ISO OPLAH (Homo sapiens) 6480464 Valproic Acid results in decreased expression of OPLAH mRNA CTD PMID:29154799 valproic acid increases methylation ISO OPLAH (Homo sapiens) 6480464 Valproic Acid results in increased methylation of OPLAH gene CTD PMID:29154799 valproic acid affects expression ISO OPLAH (Homo sapiens) 6480464 Valproic Acid affects the expression of OPLAH mRNA CTD PMID:25979313
